Evidence-based use of scalable biomarkers to increase diagnostic efficiency and decrease the lifetime costs of autism.
Saved in:
| Title: | Evidence-based use of scalable biomarkers to increase diagnostic efficiency and decrease the lifetime costs of autism. |
|---|---|
| Authors: | Frazier TW; Department of Psychology, John Carroll University, University Heights, Ohio, USA., Coury DL; Department of Developmental and Behavioral Pediatrics, Nationwide Children's Hospital, Columbus, Ohio, USA., Sohl K; Department of Child Health, University of Missouri, Columbia, Missouri, USA., Wagner KE; Quadrant Biosciences, Inc., Syracuse, New York, USA., Uhlig R; Quadrant Biosciences, Inc., Syracuse, New York, USA., Hicks SD; Department of Pediatrics, Division of Academic General Pediatrics, Penn State College of Medicine, Hershey, Pennsylvania, USA., Middleton FA; Department of Neuroscience & Physiology, State University of New York Upstate Medical University, Syracuse, New York, USA.; Department of Pediatrics, State University of New York Upstate Medical University, Syracuse, New York, USA. |
| Source: | Autism research : official journal of the International Society for Autism Research [Autism Res] 2021 Jun; Vol. 14 (6), pp. 1271-1283. Date of Electronic Publication: 2021 Mar 08. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101461858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-3806 (Electronic) Linking ISSN: 19393806 NLM ISO Abbreviation: Autism Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
